Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Conference Attendance in H1 2026

January 20, 2026

What is the news ?

Nicox announced its participation in several major conferences during the first half of 2026, including presentations of key scientific data from the NCX 470 Denali and Whistler studies at the American Glaucoma Society Annual Meeting.

What does it mean ?

These presentations increase the visibility of NCX 470 among glaucoma specialists, investors and potential partners while supporting the product’s regulatory and commercial positioning.

What are the next steps ?

Nicox will present the NCX 470 data at the American Glaucoma Society Annual Meeting in February 2026 and participate in multiple investor and industry conferences throughout the first half of the year.
View Press Release Corporate presentation Contact us
Previous
Next